Systemic inflammation, disease activity, and the serum levels of TIMP-1 and IL-6 in patients with MPA with motor neuropathy were significantly higher than those in patients with MPA without motor neuropathy. This evidence concerns the gene TIMP1 and microscopic polyangiitis.